Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis

M. Montemurro, H. Gelderblom, U. Bitz, J. Schütte, J. Y. Blay, H. Joensuu, J. Trent, S. Bauer, P. Rutkowski, F. Duffaud, D. Pink

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint Dive into the research topics of 'Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences